1. Home
  2. NOTE vs SCLX Comparison

NOTE vs SCLX Comparison

Compare NOTE & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTE
  • SCLX
  • Stock Information
  • Founded
  • NOTE 2013
  • SCLX 2011
  • Country
  • NOTE United States
  • SCLX United States
  • Employees
  • NOTE N/A
  • SCLX N/A
  • Industry
  • NOTE EDP Services
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOTE Technology
  • SCLX Health Care
  • Exchange
  • NOTE Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • NOTE 132.5M
  • SCLX 130.1M
  • IPO Year
  • NOTE N/A
  • SCLX N/A
  • Fundamental
  • Price
  • NOTE $0.80
  • SCLX $0.61
  • Analyst Decision
  • NOTE Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • NOTE 7
  • SCLX 3
  • Target Price
  • NOTE $3.30
  • SCLX $11.33
  • AVG Volume (30 Days)
  • NOTE 579.3K
  • SCLX 184.3K
  • Earning Date
  • NOTE 11-12-2024
  • SCLX 11-26-2024
  • Dividend Yield
  • NOTE N/A
  • SCLX N/A
  • EPS Growth
  • NOTE N/A
  • SCLX N/A
  • EPS
  • NOTE N/A
  • SCLX N/A
  • Revenue
  • NOTE $125,062,000.00
  • SCLX $50,833,000.00
  • Revenue This Year
  • NOTE N/A
  • SCLX $32.77
  • Revenue Next Year
  • NOTE $7.25
  • SCLX $50.71
  • P/E Ratio
  • NOTE N/A
  • SCLX N/A
  • Revenue Growth
  • NOTE N/A
  • SCLX 9.41
  • 52 Week Low
  • NOTE $0.74
  • SCLX $0.54
  • 52 Week High
  • NOTE $2.27
  • SCLX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • NOTE 28.39
  • SCLX 28.71
  • Support Level
  • NOTE $0.77
  • SCLX $0.73
  • Resistance Level
  • NOTE $0.98
  • SCLX $1.14
  • Average True Range (ATR)
  • NOTE 0.09
  • SCLX 0.11
  • MACD
  • NOTE -0.01
  • SCLX -0.04
  • Stochastic Oscillator
  • NOTE 17.29
  • SCLX 11.99

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: